INTELLIGENT BIO SOLUTIONS INC. - 8-K Filing

Intelligent Bio Solutions reports fiscal 2026 revenue of $4.2M (+38% YoY), driven by reader installed base growth and higher-margin cartridge sales, with gross margin expanding to 48.63% (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $INBS

Read the full article at SEC EDGAR

More Regulatory news